Ark Fintech Innovation ETF (ARKF)
$38.07 0.35 (0.93%)
20:00 EDT ARKF Stock Quote Delayed 30 Minutes
Previous Close $38.07
Market Cap 5.73M
PE Ratio -
Volume (Avg. Vol.) 1.44M
Day's Range 36.85 - 38.08
52-Week Range 16.94 - 42.33
Dividend & Yield N/A (N/A)
ARKF Stock Predictions, Articles, and Ark Fintech Innovation ETF News
- From InvestorPlace
- From the Web
Rather than investing in individual financial stocks, a risky bet these days, investors may want to consider some unique financial ETFs.
When you buy a fintech ETF, you'll be embracing stocks at the forefront of emerging technologies like blockchain and trends such as the gig economy.
For investors willing to take on a bit more risk in search of true disruption in the tech space, there are a slew of thematic tech ETFs that offer dedicated exposure to some of the most compelling tech themes; exposure that is hard to come by in traditional tech ETFs.
From Seeking Alpha
Carlyle Group (CG -1.9%) makes an investment in TriNetX, a health research network that aims to optimize clinical research to bring new therapies to market faster, and will acquire a majority stake in the firm.Terms of the transaction weren't disclosed.Equity capital for the investment came from Carlyle Partners VII, an $18.5B fund that makes majority and strategic minority investments primarily in the U.S. in targeted industries, including healthcare.Founded in 2013, TriNetX has built a global network of research hospitals and academic institutions, biotech and pharmaceutical companies, contract research organizations, and other specialty data partners.The firm helps researchers apply a data-driven approach to health research by providing web-based, on-demand access to harmonized global electronic health record, and claims data with a suite of intuitive analytics.
From Seeking Alpha
Carlyle Group (CG -0.2%) will acquire a majority stake in Victory Innovations, a maker of electrostatic sprayers used to disinfect offices, airplanes, schools, and other facilities, a business that's seen increased demand as a result of the COVID-19 pandemic.Carlyle's investment will help Victory accelerate its growth, including planned expansion in key markets in Asia, Europe, Latin America, and Africa.Terms of the deal weren't disclosed; Carlyle expects it to close by the end of the month.Equity for the transaction will come from Carlyle Partners VII, an $18.5B fund primarily focused on majority and strategic minority investments in the U.S.